文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results.

作者信息

Pastorino Ugo, Bellomi Massimo, Landoni Claudio, De Fiori Elvio, Arnaldi Patrizia, Picchio Maria, Pelosi Giuseppe, Boyle Peter, Fazio Ferruccio

机构信息

Division of Thoracic Surgery, Istituto Nazionale Tumori, Milan, Italy.

出版信息

Lancet. 2003 Aug 23;362(9384):593-7. doi: 10.1016/S0140-6736(03)14188-8.


DOI:10.1016/S0140-6736(03)14188-8
PMID:12944057
Abstract

BACKGROUND: Low-dose spiral CT of the chest effectively detects early-stage lung cancer in high-risk individuals. The high rate of benign nodules and issues of making a differential diagnosis are critical factors that currently hamper introduction of large-scale screening programmes. We investigated the efficacy of repeated yearly spiral CT and selective use of positron emission tomography (PET) in a large cohort of high-risk volunteers. METHODS: We enrolled 1035 individuals aged 50 years or older who had smoked for 20 pack-years or more. All patients underwent annual low-dose CT, with or without PET, for 5 years. Lesions up to 5 mm were deemed non-suspicious and low-dose CT was repeated after 12 months (year 2). FINDINGS: By year 2, 22 cases of lung cancer had been diagnosed (11 at baseline, 11 at year 2). 440 lung lesions were identified in 298 (29%) participants, and 95 were recalled for high-resolution contrast CT. PET scans were positive in 18 of 20 of the identified cancer cases. Six patients underwent surgical biopsy for benign disease because of false-positive results (6% of recalls, 22% of invasive procedures). Complete resection was achieved in 21 (95%) lung cancers, 17 (77%) were pathological stage I (100% at year 2), and the mean tumour size was 18 mm. There were no interval lung cancers in the 2.5 years of follow-up (average time on study from randomisation to last contact), although 19 individuals were diagnosed with another form of cancer (two deaths and 17 non-fatal admissions). INTERPRETATION: Combined use of low-dose spiral CT and selective PET effectively detects early lung cancer. Lesions up to 5 mm can be checked again at 12 months without major risks of progression.

摘要

相似文献

[1]
Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results.

Lancet. 2003-8-23

[2]
Lung cancer screening with low-dose spiral computed tomography.

Am Surg. 2005-12

[3]
Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography.

Lung Cancer. 2007-12

[4]
Early lung cancer detection using spiral computed tomography and positron emission tomography.

Am J Respir Crit Care Med. 2005-6-15

[5]
Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.

Lung Cancer. 2005-5

[6]
Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers.

Eur Radiol. 2004-4

[7]
Can lung cancer screening by computed tomography be effective in areas with endemic histoplasmosis?

J Thorac Cardiovasc Surg. 2010-10-8

[8]
Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial.

Lung Cancer. 2008-3

[9]
Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules.

Lung Cancer. 2008-9

[10]
Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.

Am J Respir Crit Care Med. 2015-5-15

引用本文的文献

[1]
Comparison of Efficacy and Safety of Different Guided Technologies Combined With Ultrathin Bronchoscopic Biopsy for Peripheral Pulmonary Lesions.

Clin Respir J. 2024-10

[2]
Blood microRNA testing in participants with suspicious low-dose CT findings: follow-up of the BioMILD lung cancer screening trial.

Lancet Reg Health Eur. 2024-9-16

[3]
Which is a real valuable screening tool for lung cancer and measure thoracic diseases, chest radiography or low-dose computed tomography?: A review on the current status of Japan and other countries.

Medicine (Baltimore). 2024-5-10

[4]
Diagnostic efficacy of intraoperative histopathological examination of lesions with unknown diagnosis suspicious for malignancy.

Heliyon. 2023-11-17

[5]
NAD(P)H Quinone Oxidoreductase-1 Expression Promotes Self-Renewal and Therapeutic Resistance in Non-Small Cell Lung Cancer.

Genes (Basel). 2023-2-28

[6]
A deep learning model based on the attention mechanism for automatic segmentation of abdominal muscle and fat for body composition assessment.

Quant Imaging Med Surg. 2023-3-1

[7]
Understanding patient barriers and facilitators to uptake of lung screening using low dose computed tomography: a mixed methods scoping review of the current literature.

Respir Res. 2022-12-23

[8]
Modern Diagnostic Imaging Technique Applications and Risk Factors in the Medical Field: A Review.

Biomed Res Int. 2022

[9]
Ensemble Learning Framework with GLCM Texture Extraction for Early Detection of Lung Cancer on CT Images.

Comput Math Methods Med. 2022

[10]
MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway.

Pharmaceuticals (Basel). 2022-2-28

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索